Search

everythinglearnresearchcommunity

for

Search:↓

The health of the sentinel lymph node is the best indicator of survival for patients with thick skin cancer.

A specific genetic trait in tumor cells is linked to longer survival without disease in certain lymphoma patients.

Genetic differences affect breast cancer treatment success with tamoxifen in South African patients.

Radiotherapy is a good option when further surgery for skin cancer isn't preferred, but more research is needed to compare it with other methods.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

Microsurgical reconstruction effectively covers complex scalp defects but doesn't improve survival for cancer-related cases.

Continued research and awareness are needed to improve treatments for androgen-dependent diseases.

Hair transplantation on a reconstructed scalp can effectively improve hair growth and appearance.

KRT80 may worsen cancer by increasing growth and spread, but its full effects on treatment and outcomes need more research.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Chemotherapy may help with survival in children with medulloblastoma, but more research is needed.

Adding celecoxib to chemotherapy improves survival and quality of life for gastric cancer patients with positive COX-2.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Patients and oncologists prioritize survival benefits, while payers focus on treatment costs.

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

In 2023, there were major advancements in skin and venereal disease treatments.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Busulfan/cyclophosphamide and total bone irradiation are equally effective for AML transplants.

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.

Ripretinib is effective and safe for treating advanced GIST in Chinese patients, particularly for non-gastric GISTs.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

The treatment combination is effective and generally safe for lung cancer.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.